- Home
- NRIX vs NWBI Comparison
NRIX vs NWBI Comparison
Compare NRIX & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIX | NWBI |
|---|---|---|
| Founded | 2009 | 1896 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | NRIX | NWBI |
|---|---|---|
| Price | $26.16 | $15.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $30.50 | $14.50 |
| AVG Volume (30 Days) | ★ 976.1K | 795.6K |
| Earning Date | 04-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 5.82% |
| EPS Growth | N/A | ★ 16.46 |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | N/A | $6.29 |
| Revenue Next Year | $48.05 | $5.06 |
| P/E Ratio | ★ N/A | $21.59 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.20 | $11.25 |
| 52 Week High | $28.23 | $16.16 |
Technical Indicators
Market Signals| Indicator | NRIX | NWBI |
|---|---|---|
| Relative Strength Index (RSI) | 56.11 | 46.43 |
| Support Level | $14.63 | $15.07 |
| Resistance Level | $28.23 | $15.47 |
| Average True Range (ATR) | 0.94 | 0.19 |
| MACD | -0.19 | -0.06 |
| Stochastic Oscillator | 34.11 | 31.45 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.